Vimarsana
Biggest News Aggregation in the World

Inflection Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflection Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflection Biosciences Today - Breaking & Trending Today

Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies - Vimarsana News

Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies

Mysthera Therapeutics AG, a company developing first-in-class, oral therapeutics to treat complex autoimmune diseases, launched today with $3.5 million seed capital from founding investor Forty51 Ventures. The capital will be used to advance its portfolio of pre-clinical stage, pan-PIM kinase inhibitors to uniquely modulate multi-lineage immune cell functions.

Source: yahoo.com
Irish drug developer signs licensing deal for autoimmune therapies - Vimarsana News

Irish drug developer signs licensing deal for autoimmune therapies

Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics

Mysthera Therapeutics Raises $3.5M in Seed Funding - Vimarsana News

Mysthera Therapeutics Raises $3.5M in Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!